These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 35164530)

  • 1. Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic.
    Focosi D; Maggi F; McConnell S; Casadevall A
    Future Microbiol; 2022 Mar; 17():219-221. PubMed ID: 35164530
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial introduction and spread of the SARS-CoV-2 AY.4.2.1 Delta variant in Bulgaria, a genomic insight.
    Alexiev I; Giovanetti M; Cella E; Ivanov I; Stoikov I; Donchev D; Grigorova L; Gancheva A; Dimitrova R; Korsun N; Trifonova I; Philipova I; Dobrinov V; Grigorova I; Kantardjiev T; Christova I; Ciccozzi M
    J Med Virol; 2022 Dec; 94(12):6060-6064. PubMed ID: 35902787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.
    Baj A; Novazzi F; Drago Ferrante F; Genoni A; Tettamanzi E; Catanoso G; Dalla Gasperina D; Dentali F; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):2010-2015. PubMed ID: 34651569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
    Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
    Viruses; 2022 May; 14(6):. PubMed ID: 35746637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencing.
    Mannsverk S; Bergholm J; Palanisamy N; Ellström P; Kaden R; Lindh J; Lennerstrand J
    Virol J; 2022 Oct; 19(1):164. PubMed ID: 36258215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic.
    Umair M; Ikram A; Rehman Z; Haider SA; Ammar M; Badar N; Ali Q; Rana MS; Salman M
    J Med Virol; 2022 Oct; 94(10):4869-4877. PubMed ID: 35754094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging mutation patterns in SARS-CoV-2 variants.
    Ostrov DA; Knox GW
    Biochem Biophys Res Commun; 2022 Jan; 586():87-92. PubMed ID: 34837837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first three waves of the Covid-19 pandemic hint at a limited genetic repertoire for SARS-CoV-2.
    Wassenaar TM; Wanchai V; Buzard G; Ussery DW
    FEMS Microbiol Rev; 2022 May; 46(3):. PubMed ID: 35076068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimodular effects of D614G mutation on the spike glycoprotein of SARS-CoV-2 enhance protein processing, membrane fusion, and viral infectivity.
    Jiang X; Zhang Z; Wang C; Ren H; Gao L; Peng H; Niu Z; Ren H; Huang H; Sun Q
    Signal Transduct Target Ther; 2020 Nov; 5(1):268. PubMed ID: 33203835
    [No Abstract]   [Full Text] [Related]  

  • 12. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
    Huang SW; Miller SO; Yen CH; Wang SF
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 variant with the spike protein mutation F306L in the southern border provinces of Thailand.
    Sila T; Surasombatpattana S; Rajborirug S; Laochareonsuk W; Choochuen P; Kongkamol C; Ingviya T; Prompat N; Mahasirimongkol S; Sangkhathat S; Aiewsakun P
    Sci Rep; 2024 Apr; 14(1):7729. PubMed ID: 38565881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
    Saito A; Irie T; Suzuki R; Maemura T; Nasser H; Uriu K; Kosugi Y; Shirakawa K; Sadamasu K; Kimura I; Ito J; Wu J; Iwatsuki-Horimoto K; Ito M; Yamayoshi S; Loeber S; Tsuda M; Wang L; Ozono S; Butlertanaka EP; Tanaka YL; Shimizu R; Shimizu K; Yoshimatsu K; Kawabata R; Sakaguchi T; Tokunaga K; Yoshida I; Asakura H; Nagashima M; Kazuma Y; Nomura R; Horisawa Y; Yoshimura K; Takaori-Kondo A; Imai M; ; Tanaka S; Nakagawa S; Ikeda T; Fukuhara T; Kawaoka Y; Sato K
    Nature; 2022 Feb; 602(7896):300-306. PubMed ID: 34823256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of new SARS-CoV-2 variant Omicron (B.1.1.529) on vaccine efficacy, its correlation to Delta variants: A computational approach.
    Ranjan P; Neha ; Devi C; Devar KA; Das P
    Microb Pathog; 2022 Aug; 169():105619. PubMed ID: 35690234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D614G mutations in the SARS-CoV-2 spike protein: Implications for viral infectivity, disease severity and vaccine design.
    Groves DC; Rowland-Jones SL; Angyal A
    Biochem Biophys Res Commun; 2021 Jan; 538():104-107. PubMed ID: 33199022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7.
    Peters MH; Bastidas O; Kokron DS; Henze CE
    Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021.
    Ghosh AK; Kaiser M; Molla MMA; Nafisa T; Yeasmin M; Ratul RH; Sharif MM; Akram A; Hosen N; Mamunur R; Amin MR; Islam A; Hoque ME; Landt O; Lytton SD
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.